Get Newsletter
Alzheimer Research Forum - Networking for a Cure Alzheimer Research Forum - Networking for a CureAlzheimer Research Forum - Networking for a Cure
  
What's New HomeContact UsHow to CiteGet NewsletterBecome a MemberLogin          
Papers of the Week
Current Papers
ARF Recommends
Milestone Papers
Search All Papers
Search Comments
News
Research News
Drug News
Conference News
Research
AD Hypotheses
  AlzSWAN
  Current Hypotheses
  Hypothesis Factory
Forums
  Live Discussions
  Virtual Conferences
  Interviews
Enabling Technologies
  Workshops
  Research Tools
Compendia
  AlzGene
  AlzRisk
  Antibodies
  Biomarkers
  Mutations
  Protocols
  Research Models
  Video Gallery
Resources
  Bulletin Boards
  Conference Calendar
  Grants
  Jobs
Early-Onset Familial AD
Overview
Diagnosis/Genetics
Research
News
Profiles
Clinics
Drug Development
Companies
Tutorial
Drugs in Clinical Trials
Disease Management
About Alzheimer's
  FAQs
Diagnosis
  Clinical Guidelines
  Tests
  Brain Banks
Treatment
  Drugs and Therapies
Caregiving
  Patient Care
  Support Directory
  AD Experiences
Community
Member Directory
Researcher Profiles
Institutes and Labs
About the Site
Mission
ARF Team
ARF Awards
Advisory Board
Sponsors
Partnerships
Fan Mail
Support Us
Return to Top
Home: News
News
News Search  
Sorting Cell Rescue in Spinal Muscular Atrophy
25 June 2012. Rescuing motor neurons improves symptoms in mouse models of spinal muscular atrophy (SMA), but the animals do not live any longer than untreated controls. Systemic repair, on the other hand, restores normal lifespan, suggesting that other tissues contribute to pathology. But which cells? In the June 20 Journal of Neuroscience, scientists from Johns Hopkins University, Baltimore, Maryland, report that muscle tissue might need rescue in SMA as well. Although it is unlikely that the mouse model used perfectly parallels the human disease, the work has implications for SMA therapies currently under trial.

Spinal muscular atrophy affects peripheral motor neurons in infants and children. The muscle weakness in SMA results from defects in the survival of motor neuron (SMN) gene. Despite its cell-specific name, SMN pervades all cell types at low levels, said senior author Charlotte Sumner. By selectively replacing SMN in specific tissues, the team addressed whether the neuromuscular junction (NMJ) defects observed in SMA mice are due solely to the lack of neuronal SMN, or whether muscle SMN deficiency also contributes. Joint first authors Tara Martinez and Lingling Kong bred SMA mice carrying a Cre-dependent, inducible SMN allele to mice expressing Cre in neurons or in muscle.

Martinez and colleagues found that young SMA mice expressing SMN in motor neurons moved similarly to wild-type mice. They spent the same amount of time upright, traveled the same distance, and reared on their hind legs as often. At 10 days of age, they possessed one-quarter more motor neurons, in the lumbar 1 segment of the spinal cord, than did SMA mice without any Cre. According to electrophysiology experiments, neural SMN restored NMJ function to normal.

Restoring SMN to muscles led to wider muscle fibers and thicker muscles than in SMA controls or SMA mice expressing a good copy of SMN in neurons. However, that muscle bulk did not boost mouse mobility. The muscle-SMN animals had no increase in motor neuron numbers or NMJ transmissions.

These results confirm that motor neurons are the crucial site of SMA pathology, according to Sumner. Unfortunately, “if we put SMN back into motor neurons alone ... there was minimal benefit to the overall survival of the mice,” Sumner said. Neuronal rescue afforded an extra week of life over typical SMA mice—the same as muscle rescue. In comparison, other researchers have shown that adding back SMN systemically extends survival by more than a year (Hua et al., 2011). “That suggests that the disease is more complicated than simply having vulnerable motor neurons,” Sumner concluded. She believes that other cell types contribute to the pathology. Because muscle expression of SMN also helped the animals slightly, she thinks SMN may play a secondary role in muscle, perhaps in myofiber growth.

Christine DiDonato of Children’s Hospital of Chicago Research Center in Illinois obtained similar results restoring SMN in the motor neurons of SMA mice (Gogliotti et al., 2012). The interesting thing, she told Alzforum, was that “the animals … essentially died on their feet.” It was not motor neuron pathology that killed them, but heart failure caused by defects in their autonomic nervous systems, DiDonato suspects (Heier et al., 2010; Bevan et al., 2010; Shababi et al., 2010). This suggests that motor neurons are not the only nerves that rely on SMN to function. Children with SMA also have high rates of heart arrhythmias, DiDonato told ARF.

“I think you have to consider the whole neural circuit,” said Arthur Burghes of Ohio State University in Columbus, who was not involved in either paper. Interneurons, for example, might also suffer from lack of SMN, he suggested. Burghes was skeptical about the importance of muscle. Sumner agreed that muscles are less critical to SMA than are motor neurons, but is developing mice that have SMN restored to both muscle and motor neurons to look for additive or synergistic effects.

Doctors are currently testing a therapy to restore proper SMN transcripts to children with SMA. In this trial, the treatment will be injected intrathecally so it reaches the central nervous system. Sumner is optimistic that SMN in the central nervous system will be beneficial, as long as children get treatment before motor neurons begin to disappear. However, another possible interpretation of her results is that non-nervous tissues such as muscle will need SMN back, too. “Extended survival may unmask other deficits,” as it did in the mice that suffered heart failure, DiDonato speculated. “Further work is required to understand other organ systems that are important in SMA.”—Amber Dance.

Reference:
Martinez TL, Kong L, Wang X, Osborne MA, Crowder ME, Van Meerbeke JP, Xu X, Davis C, Wooley J, Goldhamer DJ, Lutz CM, Rich MM, Sumner CJ. Survival Motor Neuron protein in motor neurons determines synaptic integrity in spinal muscular atrophy. J Neurosci. 2012 Jun 20;32(25):8703-15. Abstract

 
  Submit a Comment on this News Article
Cast your vote and/or make a comment on this news article. 

If you already are a member, please login.
Not sure if you are a member? Search our member database.

*First Name  
*Last Name  
Country or Territory:
*Login Email Address  
*Password    Minimum of 8 characters
*Confirm Password  
Stay signed in?  

I recommend the Primary Papers

Comment:

(If coauthors exist for this comment, please enter their names and email addresses at the end of the comment.)

References:


*Enter the verification code you see in the picture below:


This helps Alzforum prevent automated registrations.

Terms and Conditions of Use:Printable Version

By clicking on the 'I accept' below, you are agreeing to the Terms and Conditions of Use above.
Print this page
Email this page
Alzforum News
Papers of the Week
Text size
Share & Bookmark
ADNI Related Links
ADNI Data at LONI
ADNI Information
DIAN
Foundation for the NIH
AddNeuroMed
neuGRID
Desperately

Antibodies
Cell Lines
Collaborators
Papers
Research Participants
Copyright © 1996-2013 Alzheimer Research Forum Terms of Use How to Cite Privacy Policy Disclaimer Disclosure Copyright
wma logoadadad